FAKTOR-OPTIONSSCHEIN - MERCK & CO. | Market Closed - Börse Stuttgart 15:00:06 2024-05-31 EDT | ||
| 11.01 EUR | -0.45% |
|
| Current month | +7.10% | ||
| 1 month | +7.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 11.01 | -0.45% |
| 24-05-30 | 11.06 | +1.47% |
| 24-05-29 | 10.9 | +1.21% |
| 24-05-28 | 10.77 | +9.12% |
| 24-05-27 | 9.87 | -1.40% |
Delayed Quote Börse Stuttgart
Last update May 31, 2024 at 03:00 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MG1SPR |
| ISIN | DE000MG1SPR9 |
| Date issued | 2024-04-05 |
| Strike | 166 $ |
| Maturity | Unlimited |
| Parity | 3.43 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.48 € |
|---|---|
| Lowest since issue | 9.31 € |
| Spread | 0.01 € |
| Spread % | 0.09% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5
USD
Average target price
141.9
USD
Spread / Average Target
+13.01%
- Stock Market
- Certificates
- Certificat
